Position in ZLAB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,581,306
+$1,386,121 QoQ
Shares Held
243,557
+34.5% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ZLAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AMERIPRISE FINANCIAL INC holds $4,232,542,246 across 191 Biotechnology names. ZLAB ranks #80 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,633,481 | $1,175,954,602 | |
| 2 | INSM |
INSMED Inc
|
3,057,718 | $499,998,043 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,608,476 | $304,082,386 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
319,677 | $246,995,233 | |
| 5 | ARGX |
Argenx SE
|
215,910 | $157,668,275 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,579,793 | $153,634,868 | |
| 7 | ASND |
Ascendis Pharma A/S
|
476,466 | $108,982,067 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,248,521 | $92,715,166 |
All Filings in ZLAB
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,581,306 | 243,557 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,195,185 | 181,133 | Shares | Defined | 2026-02-17 | |
| 2023-12-31 | $493,470 | 18,056 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $411,980 | 16,947 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $504,741 | 18,202 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $686,484 | 20,640 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $525,000 | 17,101 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $813,959 | 23,800 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,129,909 | 32,581 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,462,070 | 33,244 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $35,849,010 | 570,390 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $41,878,506 | 397,367 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $51,136,834 | 288,925 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $34,119,383 | 255,710 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $3,107,000 | 22,957 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $2,539,346 | 30,532 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $2,501,926 | 30,463 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,600,204 | 31,084 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||